Disseminated histoplasmosis
ICD-10 A28.2 is a billable code used to indicate a diagnosis of disseminated histoplasmosis.
Disseminated histoplasmosis is a systemic fungal infection caused by the organism Histoplasma capsulatum, which is primarily found in soil enriched with bird or bat droppings. The infection can occur after inhalation of spores, leading to pulmonary histoplasmosis, which may progress to disseminated disease, particularly in immunocompromised individuals. Symptoms of disseminated histoplasmosis can include fever, weight loss, fatigue, cough, and respiratory distress. The disease can affect multiple organ systems, including the liver, spleen, and bone marrow, leading to complications such as anemia and thrombocytopenia. Diagnosis is typically made through clinical evaluation, serological tests, and culture of the organism. Treatment involves antifungal medications, and early intervention is crucial for improving outcomes, especially in high-risk populations such as those with HIV/AIDS or other immunosuppressive conditions.
Detailed clinical history, laboratory results, and treatment plans.
Patients presenting with fever, weight loss, and respiratory symptoms.
Ensure documentation reflects the severity and extent of the disease.
Pulmonary function tests, imaging studies, and treatment response.
Patients with respiratory distress and a history of exposure to endemic areas.
Document any pulmonary complications and response to antifungal therapy.
Used to confirm diagnosis in suspected cases of disseminated histoplasmosis.
Document the reason for testing and results.
Infectious disease specialists should ensure comprehensive documentation of test results.
Common symptoms include fever, weight loss, cough, fatigue, and respiratory distress. In severe cases, it can affect multiple organ systems.
